A Study Comparing Rituximab/Bendamustin(RB) Alternating With Rituximab/Bendamustin/Cytarabin(RBAC) With RB Therapy in Elderly Patients With Mentle Cell Lymphoma

Clinical trial NCT05245656 · RECRUITING

Trial details

NCT number: NCT05245656
Sponsor: Kim, Seok Jin
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Mantle Cell Lymphoma

Start date: 2022-10-18
Primary completion: 2029-12-31
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.